Skip to content
Doctor licensed in Poland · licence no. 3211301 Prescription on the EU model Every day, 6am to midnight (Malta time)

Lipitor and atorvastatin: strengths, muscle symptoms, interactions

Lipitor contains atorvastatin, a statin that lowers LDL cholesterol and other blood fats and is also used to reduce the risk of heart disease in adults at high risk. This page sets out the Lipitor strengths authorised in Malta, the doses in the product information, the muscle symptoms and other side effects to report, the medicines that interact with atorvastatin and how a request for it is assessed.

What Lipitor contains and which strengths are authorised

Lipitor contains atorvastatin, a member of the group of medicines known as statins, or HMG-CoA reductase inhibitors. The Medicines Authority register lists six authorised Lipitor products: 10 mg film-coated tablets (MA1396/00901), chewable tablets of 5, 10, 20 and 40 mg (MA1396/00902 to MA1396/00905) and 10 mg tablets authorised as a parallel import (PI770/12702A). All six are classified as prescription-only medicines (POM). Three older authorisations for 20, 40 and 80 mg film-coated tablets are recorded as withdrawn.

Atorvastatin is also authorised under other names. The register lists 45 authorised products with atorvastatin as the only active substance and 13 authorised combinations, among them tablets that combine atorvastatin with ezetimibe; all of them are POM. A combination tablet already contains the statin, so plain atorvastatin is not added to it unless the doctor says so. Check the composition on each pack, and ask the pharmacist when two packs look different.

What atorvastatin is used for

The summary of product characteristics (SmPC) lists two kinds of use (section 4.1). The first is raised blood fats. Alongside diet, Lipitor lowers total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides in adults, adolescents and children aged 10 or over with primary hypercholesterolaemia, including the inherited heterozygous form of familial hypercholesterolaemia, or with combined (mixed) hyperlipidaemia, when diet and other non-drug measures are not enough. In adults with homozygous familial hypercholesterolaemia it is used together with other lipid-lowering treatments.

The second is prevention: Lipitor is used to prevent cardiovascular events in adults estimated to have a high risk of a first event, together with correcting other risk factors. Section 5.1 of the SmPC states that, in clinical studies, lowering total cholesterol, LDL cholesterol and apolipoprotein B has reduced the risk of cardiovascular events and cardiovascular death; this is a study finding, not a promise for any one person.

Raised cholesterol is measured with a blood test, and whether it needs a medicine depends on your overall risk as well as on the number. Our guide to high cholesterol explains the test. The leaflet reminds you to keep to a cholesterol-lowering diet during treatment.

How atorvastatin lowers cholesterol

Atorvastatin blocks HMG-CoA reductase, the enzyme that controls an early, rate-limiting step in the liver's production of cholesterol (SmPC, section 5.1). With less cholesterol being made, the liver puts more LDL receptors on its cell surface, and these take up more LDL from the blood. The SmPC describes the result as lower LDL production and fewer LDL particles.

In a dose-response study described in section 5.1, atorvastatin lowered total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides, the size of the fall varied across the doses studied, and HDL cholesterol rose by variable amounts. These are study results, not a prediction for you: your own change is measured with a repeat blood test.

The half-life of atorvastatin in the blood is about 14 hours, while its effect on the enzyme lasts about 20 to 30 hours because active breakdown products contribute to it (section 5.2). The SmPC allows the daily dose to be taken at any time of day, with or without food (section 4.2).

Doses in the summary of product characteristics

The dose is individual: the SmPC sets it according to your LDL cholesterol at the start, the goal of treatment and your response (section 4.2). You should be on a standard cholesterol-lowering diet before you start and stay on it during treatment. The usual starting dose is 10 mg once a day, changes are made at intervals of 4 weeks or more, and the maximum is 80 mg once a day. According to the SmPC, a response is evident within 2 weeks, and the maximum response is usually reached within 4 weeks.

No dose adjustment is needed for kidney impairment. In liver impairment atorvastatin is used with caution, and it is not used in active liver disease. With the hepatitis C medicines elbasvir/grazoprevir, or with letermovir, the dose should not exceed 20 mg a day. Atorvastatin is not indicated in children under 10.

The leaflet for the film-coated tablets asks you to swallow them whole with a drink of water and to take your dose at the same time each day. If you forget a dose, take the next one at the usual time and do not take a double dose. If you want to stop the treatment, ask the doctor or the pharmacist first.

SituationDose in the SmPC
Primary hypercholesterolaemia and mixed hyperlipidaemiaMost patients are controlled on 10 mg once a day; changes at intervals of 4 weeks or more, up to 80 mg
Heterozygous familial hypercholesterolaemia, adultsStart at 10 mg; adjust every 4 weeks to 40 mg; then up to 80 mg, or 40 mg combined with a bile acid sequestrant
Homozygous familial hypercholesterolaemia10 to 80 mg a day, together with other lipid-lowering treatments
Prevention of cardiovascular disease10 mg a day in the primary prevention trials; higher doses may be needed to reach the cholesterol levels in current guidelines
Heterozygous familial hypercholesterolaemia, children aged 10 and overStart at 10 mg a day; may be increased up to 80 mg according to response and tolerability

Who should not take atorvastatin

The SmPC lists the contraindications below (section 4.3). If one of them applies to you, tell the doctor before any decision about treatment. If you are pregnant or planning a pregnancy, treatment is suspended rather than reduced (section 4.6).

  • An allergy to atorvastatin or to any other ingredient of the tablets.
  • Active liver disease, or unexplained, persistent rises in liver enzymes (transaminases) to more than three times the upper limit of normal.
  • Pregnancy, breast-feeding, or being able to become pregnant without using appropriate contraception.
  • Treatment with the hepatitis C antivirals glecaprevir/pibrentasvir.

When extra care is needed

Liver function tests are recommended before you start and periodically afterwards, and atorvastatin is used with caution if you drink substantial quantities of alcohol or have had liver disease (SmPC, section 4.4). Before treatment, the SmPC also recommends measuring creatine kinase (CK), an enzyme released from damaged muscle, in the situations listed below, because they make a severe muscle reaction more likely.

In the clinical studies described in the SmPC (section 4.4), an analysis of the SPARCL study in people without coronary heart disease who had had a recent stroke or transient ischaemic attack found more haemorrhagic strokes in those started on 80 mg than on placebo, so the doctor weighs the risk carefully if you have had a bleeding stroke or a lacunar infarct. Statins as a class can raise blood sugar, and people at risk of diabetes are monitored; the SmPC states that this risk should not be a reason for stopping a statin.

Statins have rarely caused or worsened myasthenia gravis, and atorvastatin is stopped if its symptoms get worse. Interstitial lung disease has been reported in exceptional cases, with breathlessness, a dry cough and feeling generally unwell. The tablets contain lactose.

  • Reduced kidney function.
  • An underactive thyroid.
  • A personal or family history of inherited muscle disorders.
  • Earlier muscle problems with a statin or a fibrate.
  • Liver disease in the past, or substantial alcohol intake.
  • Age over 70, depending on other risk factors.
  • Other medicines or conditions that can raise the level of atorvastatin in the blood.

Muscle symptoms: what to report and when to get help

Like other statins, atorvastatin can in rare cases affect skeletal muscle, causing muscle pain (myalgia), inflammation of the muscles (myositis) or myopathy. Myopathy can progress to rhabdomyolysis, a potentially life-threatening breakdown of muscle that may lead to kidney failure (SmPC, section 4.4). Very rarely, an immune-mediated necrotising myopathy has been reported during or after statin treatment, with muscle weakness that persists after the statin is stopped.

The SmPC asks you to report muscle pain, cramps or weakness promptly, especially if you also feel unwell or have a fever. The doctor then measures CK. If it is markedly raised, treatment is stopped; if the symptoms settle and CK returns to normal, the SmPC allows atorvastatin or another statin to be reintroduced at the lowest dose with close monitoring. Report the symptom rather than quietly stopping the tablet, so that this can be decided properly.

Severe, unexplained muscle pain, tenderness or weakness, especially with dark urine, needs urgent medical assessment. In an emergency, call 112 or go to Accident and Emergency.

Medicines and foods that interact with atorvastatin

Atorvastatin is broken down by the liver enzyme CYP3A4 and carried by transport proteins, so medicines that block them raise atorvastatin levels and the risk of muscle problems (SmPC, section 4.5). The SmPC asks for potent inhibitors to be avoided where possible; if they cannot be avoided, lower starting and maximum doses and clinical monitoring are recommended. The main interactions are listed below.

Mention that you take a statin whenever any new medicine is started, including a short course of an antibiotic, and list everything you take, including medicines bought without a prescription, food supplements and herbal products.

  • Potent CYP3A4 or transporter inhibitors, such as ciclosporin, clarithromycin, telithromycin, ketoconazole, itraconazole, voriconazole, posaconazole, letermovir, some hepatitis C antivirals and HIV protease inhibitors such as ritonavir: avoided where possible, or lower doses with monitoring.
  • Glecaprevir/pibrentasvir: must not be combined with atorvastatin.
  • Moderate CYP3A4 inhibitors, such as erythromycin, diltiazem, verapamil and fluconazole, and amiodarone: a lower maximum dose and monitoring.
  • Gemfibrozil and other fibrates, ezetimibe, niacin and colchicine: the risk of muscle problems may rise.
  • Fusidic acid given by mouth or by injection: atorvastatin must not be taken with it or within 7 days of stopping it, so the statin is paused for the whole course.
  • Daptomycin: pausing atorvastatin is considered, or monitoring if both are needed.
  • Rifampicin, efavirenz and St John's wort: they can lower atorvastatin levels.
  • Warfarin and other coumarin anticoagulants: the prothrombin time is checked before starting and early in treatment, and again after a dose change.
  • Digoxin: its level rises slightly, so people taking it are monitored.
  • The contraceptive pill: atorvastatin raised the levels of norethindrone and ethinylestradiol.
  • Grapefruit juice: the leaflet advises no more than one or two small glasses a day.

Side effects listed for atorvastatin

In the placebo-controlled clinical trials described in the SmPC, slightly more people stopped treatment because of side effects with atorvastatin than with placebo (section 4.8). The table lists the main effects by frequency.

The SmPC adds that some statins have been associated with sexual dysfunction, depression, exceptional cases of interstitial lung disease and diabetes, the last depending on risk factors such as a fasting glucose of 5.6 mmol/L or more, a BMI over 30, raised triglycerides and high blood pressure.

Get medical help without delay for yellowing of the skin or the whites of the eyes, severe abdominal pain, a widespread blistering rash, or swelling of the face, lips or tongue with difficulty breathing. You can report a suspected side effect to the doctor or the pharmacist; the SmPC asks healthcare professionals to report suspected reactions to the Medicines Authority.

Frequency in the SmPCSide effects
Common (up to 1 in 10 people)Inflammation of the nose and throat, sore throat, nosebleed, allergic reactions, raised blood sugar, headache
Common, continuedConstipation, wind, indigestion, nausea, diarrhoea, muscle and joint pain, muscle spasms, joint swelling, back pain, abnormal liver tests, raised CK
Uncommon (up to 1 in 100 people)Low blood sugar, weight gain, loss of appetite, nightmares, difficulty sleeping, dizziness, tingling or numbness, taste changes, memory loss
Uncommon, continuedBlurred vision, ringing in the ears, vomiting, abdominal pain, belching, pancreatitis, hepatitis, hives, rash, itching, hair loss
Uncommon, continuedNeck pain, muscle fatigue, tiredness, chest pain, swelling (peripheral oedema), fever
Rare (up to 1 in 1,000 people)Low platelet count, nerve damage in the hands and feet, visual disturbance, cholestasis, angioedema, vasculitis
Rare, continuedBlistering skin reactions including Stevens-Johnson syndrome, myopathy, myositis, rhabdomyolysis, muscle rupture, tendon disorders
Very rare (up to 1 in 10,000 people)Anaphylaxis, hearing loss, liver failure, lupus-like syndrome, breast enlargement in men
Not knownMyasthenia gravis, ocular myasthenia, immune-mediated necrotising myopathy

Pregnancy, breast-feeding and contraception

Lipitor is contraindicated in pregnancy and while breast-feeding, and women who can become pregnant should use appropriate contraception during treatment (SmPC, sections 4.3 and 4.6). The SmPC explains that safety in pregnancy has not been established and that rare reports of congenital anomalies have been received after exposure to statins in the womb. It also notes that stopping lipid-lowering medicines during pregnancy should ordinarily have little impact on long-term risk.

If you are pregnant, trying to become pregnant or think you may be, tell the doctor. According to the SmPC, treatment is suspended for the duration of the pregnancy or until it has been established that you are not pregnant.

Atorvastatin, simvastatin and rosuvastatin

Statins differ in how they are broken down and in which medicines limit their dose. Several medicines that the atorvastatin SmPC asks to avoid where possible or to combine only at a lower dose, such as clarithromycin, erythromycin and itraconazole, are contraindicated with simvastatin, and the simvastatin SmPC gives it as a single dose in the evening; see our page on simvastatin. Rosuvastatin is described on our page about rosuvastatin, and the groups of cholesterol medicines are compared on our page on statins and cardiovascular risk. A switch from one statin to another is a decision for the doctor, who takes your other medicines and your results into account.

How a request for atorvastatin is assessed

You fill in a medical questionnaire about the medicine, your health and other medicines you take, and the doctor reviews your answers in writing. If you already take atorvastatin, it helps to have a recent lipid profile and a recent liver function result to hand. For a first prescription your answers need to show clear indications, because starting a statin depends on your overall cardiovascular risk, including blood pressure, smoking and diabetes.

If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know. There is no video call, no phone call and no live chat. The doctor may ask you for test results, may recommend that you see a doctor in Malta, or may decline. For some conditions, and in some individual cases, it is advisable to see a doctor in person; the doctor may recommend this. Unexplained muscle pain and the other warning signs above need to be examined, not assessed in writing.

If the doctor issues a prescription, you receive it as a PDF by email. You print it and bring it on paper to a pharmacy in Malta together with photo identification. Your prescription is issued in the standard EU cross-border format set out in Directive 2012/52/EU. A pharmacy in Malta may dispense it; the decision rests with the pharmacist. Take the prescription to a pharmacy within six months of the date on it; a prescription for an antibiotic cannot be dispensed more than ten days after its date of issue.

What does it cost?

Two separate costs are involved. The button on this page shows the fee for the doctor's review, and the medicine itself is paid for at the pharmacy, which can tell you the price of your pack. It is not an ePrescription and does not appear in myHealth; it is outside POYC and the Government Formulary List, and you pay for the medicine at the pharmacy in full.

The fee covers the medical consultation, not the issuing of a document. If the doctor declines on medical or legal grounds, we refund the fee. If the doctor asks you for documents, you have at least 7 days to send them in and we send you a reminder; if you ask us, we agree a longer deadline. If the case still cannot be completed, we close the request, let you know and refund the fee in full.

Who reviews your request?

Your request is reviewed by Damian Wojno, a doctor registered with the Polish Medical Chamber, licence no. 3211301. The doctor is not registered with the Medical Council of Malta.

Is Lipitor prescription-only in Malta?

All six authorised Lipitor products in the Medicines Authority register, the 10 mg film-coated tablets, the 5 to 40 mg chewable tablets and the 10 mg parallel import tablets, are classified as prescription-only medicines (POM). The same applies to all 45 authorised products with atorvastatin as the only active substance, so a pharmacy supplies them against a prescription.

How much does atorvastatin lower cholesterol?

In a dose-response study described in the SmPC, atorvastatin lowered LDL cholesterol and total cholesterol, and the size of the fall varied with the dose. These are study results, not a prediction: your own result depends on your starting level and your dose, so the doctor compares a repeat lipid profile with your result before treatment.

How quickly does atorvastatin work?

According to the SmPC, a response is evident within 2 weeks and the maximum response is usually reached within 4 weeks, which is why dose changes are made at intervals of 4 weeks or more. You will not feel the change itself: it shows on a repeat blood test.

What are the most common side effects of atorvastatin?

The SmPC lists as common inflammation of the nose and throat, headache, digestive complaints such as nausea, diarrhoea, constipation and wind, muscle and joint pain, back pain, raised blood sugar and abnormal liver tests. Less common but serious are rhabdomyolysis, liver problems and severe skin or allergic reactions.

What should I do about muscle aches on atorvastatin?

Report muscle pain, cramps or weakness to the doctor promptly, especially if you also feel unwell or have a fever, rather than stopping the tablet on your own. The doctor may measure CK and decide whether to continue, lower the dose or try another statin. Severe, unexplained muscle pain with dark urine needs urgent medical help.

Can I stop atorvastatin once my cholesterol is normal?

Talk to the doctor first. The Lipitor leaflet asks you to speak to your doctor or pharmacist if you wish to stop treatment. A result in the target range is usually measured while you take the medicine, so it does not show what would happen without it; stopping or changing the dose is a decision for the doctor, taken on your results.

Can I drink grapefruit juice with atorvastatin?

The Lipitor leaflet advises no more than one or two small glasses of grapefruit juice a day, because large quantities can change the effects of the medicine. The SmPC does not recommend large quantities, since grapefruit juice blocks the enzyme that breaks atorvastatin down.

Can a pharmacy in Malta dispense a prescription from a doctor in another EU country?

A prescription from a doctor in another EU country can be dispensed in Malta (Article 81(3) of the Medicines Act, Cap. 458) if the pharmacist can confirm the doctor's licence. The decision rests with the pharmacist, who may refuse. You need the printed document and photo identification with you at the pharmacy.